In 2023, Pfizer published research papers successively, reporting the results of randomized clinical trials on the efficacy and safety of PF-06882961 for blood sugar control in patients with type 2 diabetes, the safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06882961 in Japanese adults with type 2 diabetes from a phase 1 clinical trial, and the results of a 12-week randomized, placebo-controlled, dose-escalation phase 2 trial on the tolerability, safety, and pharmacodynamics of PF-06882961 for the treatment of type 2 diabetes
Hydroxocobalamin 1mg/ml Solution for Injection Patient Information Leaflet
Shi Q, Wang Y, Hao Q, et al
Keywords: glutathione toner, brightening toner, Korean toner, anti-aging skincare, niacinamide glow toner, pigmentation treatment.
Experience the transformative power of CoolSculpting at our cutting-edge clinic in Green Valley Ranch, Henderson, NV
Company: Novo Nordisk Inc